×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [11]
中国医学科学院 北京... [8]
中南大学 [5]
合肥物质科学研究院 [2]
四川大学 [1]
山东大学 [1]
更多...
内容类型
期刊论文 [28]
会议论文 [5]
发表日期
2021 [1]
2019 [2]
2018 [6]
2017 [2]
2016 [2]
2015 [6]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共33条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China.
期刊论文
Value in health regional issues, 2019, 卷号: 18
作者:
Li Xinyan
;
Li Weichen
;
Hou Lingping
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
bevacizumab
chemotherapy
cost-effectiveness
non–small-cell lung cancer
Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China
期刊论文
Clinical Therapeutics, 2019
作者:
Xiaoyou Li
;
Muhammad Abbas
;
Yun Li
;
Yue Teng
;
Ying Fang
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/17
bevacizumab
brain metastasis
maintenance therapy
nonsquamous non–small-cell lung cancer (NS-NSCLC)
pemetrexed-platinum doublet
pleural effusion
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)
会议论文
作者:
Yu, P.
;
Zhou, Q.
;
Song, Y.
;
Zhang, X.
;
Chen, G.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
NSCLC
real world
survival
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506)
期刊论文
LUNG CANCER, 2018, 卷号: 123
作者:
Song, Yong
;
Zhou, Qing
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
Nonsquamous non-small cell lung cancer
Gene aberration test
First-line anticancer treatment
Real-world research
Tyrosine kinase inhibitor
Chemotherapy
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China
期刊论文
Value in health regional issues, 2018, 卷号: 18, 页码: 1-7
作者:
Li Xinyan[1]
;
Li Weichen[2]
;
Hou Lingping[3]
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/04/22
bevacizumab
chemotherapy
cost-effectiveness
non–small-cell lung cancer
Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer
期刊论文
Journal of Clinical Oncology, 2018, 卷号: Vol.36 No.12, 页码: 1207-1217
作者:
Lu, S.
;
Chang, J.
;
Liu, X.
;
Shi, J.
;
Lu, Y.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/02/25
Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 卷号: 6, 期号: 20
作者:
Xu, Lu
;
Xu, Xin-Hua
;
Yuan, Cheng
;
Zhang, Jia-Yu
;
Tang, Xi
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Nonsquamous non-small cell lung cancer (Nonsquamous NSCLC)
icotinib
unknown EGFR mutation
survival analysis
adverse effect
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11, 页码: 8421-8426
作者:
Song, Xinyu
;
Chen, Dawei
;
Guo, Jun
;
Kong, Li
;
Wang, Haiyong
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
NS-NSCLC
MPE
bevacizumab
pemetrexed
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
期刊论文
BMC CANCER, 2017, 卷号: 17
作者:
Zhou, Qing
;
Song, Yong
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
Chemotherapy
China
Epidermal growth factor receptor
First-line anticancer treatment
Non-small cell lung cancer
Tyrosine kinase inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace